25 (OH) Vitamin D Levels of Patients with COVID-19 are not Associated with the Length of Hospital Stay.
25 (OH) Vitamin D Levels of Patients with COVID-19 are not Associated with
Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death
Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased
Effect of a single high dose of Vitamin D3 on cytokines, chemokines and growth factor in patients with moderate to severe COVID-19
A single high-dose of 200,000 IU of vitamin D did not elicit meaningful changes in systemic inflammatory cytokines, chemokines, or growth factor among COVID-19 patients with already...
A critical update on the role of mild and serious vitamin D deficiency prevalence and the COVID-19 epidemic in Europe.
In this study, vitamin D deficiency did not correlate to COVID-19 infection rate. COVID-19 mortality was significantly associated with vitamin D deficiency.
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19
The data from this study provides evidence that vitamin D may have an anti‐inflammatory effect on COVID‐19 patients and vitamin D may provide protective effects.
Vitamin D Levels are Associated with Blood Glucose and BMI in COVID-19 Patients, Predicting Disease Severity
High prevalence of low vitamin D levels is associated with increased disease severity due to an increased immune-inflammatory response.
Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID‐19
Though the results are not significant, Serum levels of 25(OH)D, vitamin B12, and especially zinc at the time of admission can affect clinical outcomes in COVID‐19 patients.
Seasonal UV exposure and vitamin D: association with the dynamics of COVID-19 transmission in Europe
Low UV exposure can affect the required production of vitamin D in the body, which substantially influences the dynamics of COVID-19 transmission and severity.
Vitamin D supplementation and COVID‑19 risk: a population‑based, cohort study
Supplementation with cholecalciferol or calcifediol helped subject to achieve serum 25OHD levels ≥30 ng/ml which were associated with better COVID-19 outcomes.
Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
Vitamin D deficiency has a significant dose-response relationship with adverse clinical outcomes of COVID-19 infection, including hospitalization and mortality.